Cooley Shortlisted in Four Categories for 2022 LMG Life Sciences Awards

Palo Alto – August 1, 2022 – Cooley has been shortlisted in four categories for the 2022 LMG Life Sciences Americas Awards, including three nominations for Financial & Corporate law – Corporate Firm of the Year, Licensing & Collaboration Firm of the Year, and M&A Firm of the Year – as well as a nomination in the Intellectual Property law category for Patent Strategy Firm of the Year.

The publication also recognized eight Cooley partners as finalists in their respective categories:

Financial & Corporate

• Barbara Borden, M&A Attorney of the Year

• Kay Chandler, Licensing & Collaboration Attorney of the Year

• David Peinsipp, Corporate Attorney of the Year

Intellectual Property

• Ivor Elrifi, Patent Strategy Attorney of the Year – New York

• Heidi Erlacher, Patent Strategy Attorney of the Year – Massachusetts

• Mika Reiner Mayer, Patent Strategy Attorney of the Year – California

• Michelle Rhyu, General Patent Litigator of the Year – California

Regulatory

• Sonia Nath, Regulatory Attorney of the Year: FDA Medical Device

LMG Life Sciences determines its award results through a rigorous research process involving in-depth firm submissions, practitioner interviews, client feedback and independent research.

View the full shortlists

In recent months, Cooley was recognized for its work in Europe, the Middle East and Africa at the LMG Life Sciences 2022 EMEA Awards, where it received the Venture Capital Firm of the Year award, and partners John Wilkinson and Tom Goodman were named Licensing & Collaboration Lawyer of the Year and Corporate Rising Star, respectively.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe, and a total workforce of 3,300.